A computer-aid breast cancer adjuvant diagnostic and prognostic prediction system based on deep learning-based multi-omics analysis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400081831

Enrollment

Unknown

Registered

2024-03-13

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:Pathological result

Index test:A computer-aid multimodal intergrated evaluation system

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Contains complete clinical and pathological information; ? Undergo imaging examination prior to any treatment.

Exclusion criteria

Exclusion criteria: ? Previous history of breast cancer treatment (including: anti-hormonal therapy, targeted therapy, radiotherapy, etc.);? Incomplete or poor quality MRI image;? History of puncture within 6 months prior to MRI; ? Failure to complete a full course of neoadjuvant therapy.

Design outcomes

Primary

Measure	Time frame
Area under the curve of the receiver operating characteristic;	—

Secondary

Measure	Time frame
Sensitivity ;Specificity;	—

Countries

China

Contacts

Public ContactLiu Zaiyi

Guangdong Provincial People's Hospital

liuzaiyi@gdph.org.cn+86 139 2236 9345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026